The conventional model of Rho-dependent transcription termination in bacteria requires RNAdependent translocase activity of the termination factor Rho as well as many kinetically controlled steps to execute efficient RNA release from the transcription elongation complex (EC). The involvement of the kinetically controlled steps, such as RNA binding, translocation and RNA release from the EC, means that this termination process must be kinetically coupled to the transcription elongation process. The existence of these steps in vivo has not previously been delineated in detail. Moreover, the requirement for translocase activity in Rho-dependent termination has recently been questioned by a radical view, wherein Rho binds to the elongating RNA polymerase (RNAP) prior to loading onto the mRNA. Using growth assays, microarray analyses and reporter-based transcription termination assays in vivo, we showed that slowing of the transcription elongation rate by using RNAP mutants (rpoB8 and rpoB3445) and growth of the strains in minimal medium suppressed the termination defects of five Rho mutants, three NusG mutants defective for Rho binding and the defects caused by two Rho inhibitors, Psu and bicyclomycin. These results established the existence of kinetically controlled steps in the in vivo Rho-dependent termination process and further reinforced the importance of 'kinetic coupling' between the two molecular motors, Rho and RNAP, and also argue strongly that the Rho translocation model is an accurate representation of the in vivo situation. Finally, these results indicated that one of the major roles of NusG in in vivo Rho-dependent termination is to enhance the speed of RNA release from the EC.
INTRODUCTION
In the conventional model of Rho-dependent transcription termination in bacteria, binding of Rho to the nascent RNA and its translocation along the same RNA are a prerequisite for dislodging the transcription elongation complex (EC) (model I in Fig. 1 ). This model has been derived from extensive in vitro characterization of the RNA binding, ATPase and RNA translocase activities of the hexameric Rho protein (Richardson, 2002; Banerjee et al., 2006) . More recently, an alternative model has been proposed in which Rho loads onto the EC before binding to the nascent RNA and travels with the EC during transcription elongation like other elongation factors (model II in Fig. 1 ). This putative association of Rho with RNA polymerase (RNAP) in vivo was first inferred from a ChIP-chip experiment (Mooney et al., 2009) and later from in vitro measurements (Epshtein et al., 2010) . We have recently shown that in vitro recruitment of Rho to the EC requires loading of the former onto the nascent RNA (Kalayani et al., 2011) . However, it remains possible that transfer of Rho to the EC can take place immediately after this recruitment step without invoking translocase activity (Fig. 1 , dotted line connecting the two models). In this context, it should also be mentioned that the Rho protein from Mycobacterium tuberculosis has been shown to exhibit very weak ATPase as well as translocase activity, but is still able to terminate Escherichia coli RNAP efficiently (Kalarickal et al., 2010) .
Very few studies have addressed the mechanistic aspects of the steps leading to Rho-dependent termination in vivo in general and more specifically the requirement for translocase activity. An RNAP mutant (B8), Q513P, with a low elongation rate due to its defect in NTP incorporation, was shown to suppress a Rho mutant, rho201 (F232C), leading to the hypothesis of 'kinetic coupling' between the elongating RNAP and the translocation of Rho (Jin et al., 1992) . This particular Rho mutant has not been characterized properly, and this hypothesis was based on the assumption that the apparent defect in translocase activity of rho201 was suppressed as a result of the low transcription elongation rate of B8 RNAP. More recent ChIP-chip assays support the association of Rho with the EC throughout the transcription cycle (Mooney et al., 2009; model II in Fig. 1 ) and question the requirement for the translocase activity of Rho for efficient termination.
The concept of kinetic coupling between Rho and the EC predicts that slowing of the transcription elongation rate should overcome the defects in Rho-dependent termination by suppressing the defects in all the steps which are kinetically controlled. According to the conventional model (model I in Fig. 1 ), the following steps in Rho-dependent termination are likely to be kinetically controlled.
Rho loading and activation: Rho+RNA« (Rho-RNA) inactive A(Rho-RNA) active (1)
Upon binding to the rut site (Rho utilization) through its N-terminal primary binding site (PBS), Rho undergoes a series of isomerization steps to form a translocationcompetent form (Boudvillain et al., 2010) . Although it has not been measured, it is likely that the isomerization steps should be rate-limiting and that the initial binding to the rut sequences should be diffusion-controlled. Therefore, we hypothesized that the Rho-loading and activation steps are kinetically and not thermodynamically controlled.
Translocation of Rho: (Rho-RNA) n A(Rho-RNA) n+7 (2)
Upon occupancy of the secondary binding site of Rho by RNA, its ATPase activity is activated and with each cycle of ATP hydrolysis,~7 nt of RNA is translocated by Rho (Schwartz et al., 2009 ). This process goes on until Rho reaches the EC. The translocation velocity primarily determines the speed of the whole termination reaction.
RNA release: EC-NusG+RhoARNA+RNAP+ NusG+Rho
EC-bound NusG increases the speed of RNA release by Rho in vitro (Burns et al., 1999; Chalissery et al., 2007) via a direct NusG-Rho interaction (Li et al., 1993; Sullivan & Gottesman, 1992) . In this step, the NusG-CTD (C-terminal domain) interacts with the translocating Rho, being anchored to the EC via its N-terminal domain (Chalissery et al., 2011) . It is possible that NusG-mediated enhancement of RNA release is essential on some terminators.
Here we investigated the existence of kinetically controlled steps in in vivo Rho-dependent termination by showing suppression of defects in the RNA binding, RNA translocation and RNA release activities of Rho by modulating the rate of transcription elongation. We show that reduction of the transcription elongation rate in vivo by genetic and physical means suppresses the defects of various Rho and NusG mutants and those caused by the Rho inhibitors Psu and bicyclomycin (BCM). These results provide strong evidence for the in vivo existence of several kinetically controlled steps in Rho-dependent termination, as described in model I (Fig. 1) .
METHODS
Growth assays. Three strains of E. coli MG1655, MG1655rpoB8, MG1655rpoB2 and MG16553445 (Table 1) , were transformed with pBAD plasmids expressing wild-type (WT) (pRS569) and E56K (Richardson, 2002; Banerjee et al., 2006) , involving Rho loading onto the rut site and its translocation along the mRNA prior to dislodging the EC. In this model the multiple translocation steps along the RNA and the RNA release steps are kinetically controlled and provide 'kinetic coupling' with the transcription elongation rate of the RNAP. Model II, an alternative view proposed recently (Epshtein et al., 2010; Peters et al., 2011) , describes the association of Rho with the RNAP throughout the transcription cycle. It is possible that upon loading onto the nascent RNA, Rho is transferred immediately to the elongating RNAP (shown as a dotted line; Kalayani et al., 2011) without invoking translocation.
In vivo Rho-dependent termination Fig. 3 ). Growth kinetics were followed in microtitre plates using a Spectramax microtitre plate reader, and the mean of three independent colonies was plotted. Arabinose (0.1 %) was added to the microtitre plates for Psu induction. To observe the effect of BCM, the strains were grown in the presence of the indicated amounts of the antibiotic.
For growth assays of Rho and NusG (see Fig. 5 ) mutants, different MG1655 derivatives were transformed with plasmids expressing WT or mutant derivatives of these two genes in the presence of the respective shelter plasmids. For Rho mutants, transformants were plated in the absence of IPTG to remove the Rho shelter plasmid (pHYD1201) from the strains, whereas for nusG mutants transformants were platted at 42 uC to remove the nusG shelter plasmid pHYD763.
For growth assays on minimal medium plates (see Fig. 7 ), the WT MG1655rac + strain was first transformed with pCL1920 plasmids expressing either WT or mutant rho or nusG. Then rho : : kan R and nusG : : kan R cassettes were moved into the respective strains by P1 transduction and the transductants were plated on either LuriaBertani (LB) or Minimal A medium.
In vivo termination assays. For measurement of the termination defects of the Rho mutants, RS364 (reporter: P lac -T R1 -lacZYA) and RS1128 (reporter: P lac -T R1 -trpt9-lacZYA) were transformed with the pCL1920 plasmids expressing mutants and the WT Rho plasmid to measure the defects in the presence of WT RNAP. To measure this in the presence of B8 RNAP, RS449 (reporter: P lac -T R1 -lacZYA) and RS1255 (reporter: P lac -T R1 -trpt9-lacZYA) were transformed with the mutants and WT Rho plasmids.
For the NusG mutants, RS1168 (reporter: P lac -T R1 -lacZYA) and RS1170 (reporter: P lac -T R1 -trpt9-lacZYA) were transformed with the WT and mutant NusG plasmids (pCL1920 plasmids) to estimate the in vivo termination efficiency in the presence of WT RNAP. Similarly, strains RS1169 (with P lac -T R1 -lacZYA) and RS1254 (with P lac -T R1 -trpt9-lacZYA) were transformed with WT NusG and mutant plasmids to estimate the termination efficiency with B8 RNAP. b-Galactosidase activities were determined with a SpectraMax Plus microtitre plate reader (Chalissery et al., 2007) .
In vitro transcription assays. Plasmid pRS106 (Pani et al., 2006) , with the trpt9 terminator cloned downstream of the T7A1 promoter, was used to make different DNA templates using variable primer pairs. The lac operator sequence was introduced in the template at the desired position by incorporating the sequence in the downstream primer. Linear DNA templates for transcription were made by PCR amplification on pRS106 with suitable primers.
All the transcription reactions were carried out in T-buffer (25 mM Tris/HCl, pH 8.0, 5 mM MgCl 2 , 50 mM KCl, 1 mM DTT, 0.1 mg BSA ml 21 ) at 37 uC. The reaction was initiated with 10 nM DNA and 25 nM WT RNAP or 100 nM B8 RNAP. In the B8 RNAP reactions, 400 nM s 70 was also added. In all the assays a 23-mer EC, EC 23 , was first formed by the addition of 175 mM ApU, 5 mM each of GTP and ATP, 2.5 mM CTP and [a-
32 P]CTP (3000 Ci mmol 21 ; 111 TBq mmol 21 ). For termination assays ( Fig. 2a) , this EC was chased with 25 mM of all the NTPs for 10 min. To determine GreB dependence (Fig. 2b) , the DNA template was immobilized to streptavidin-coated magnetic beads via a 59 biotin linkage. A stalled EC (RB) was formed at the lac operator site (see the cartoon in Fig. 2b ) in the presence of 100 nM lac repressor by elongating the EC 23 . This RB was then washed and chased with 250 mM NTPs in the presence or absence of GreB and 100 mM IPTG.
For the RNA release assays (Fig. 2c, d ), RB was formed in a similar way to that described above with WT and B8 RNAP on magnetic beads. The NTPs were removed by washing the immobilized RB. Then, 50 nM Rho plus 1 mM ATP was added to this RB and 5 ml of the reaction mixture was removed at the indicated time points. Gel images and quantification of the band intensities were obtained via Phosphorimager scanning.
RESULTS

Rationale
Perturbation of Rho-dependent termination. We perturbed the kinetically controlled steps in the Rho-dependent In vivo Rho-dependent termination termination process using the three methods described below, and tested the suppression of these perturbations by slowing the transcription elongation rate.
Rho inhibitors. The bacteriophage P4 coat-decorative protein Psu, and an antibiotic, BCM, interact with Rho and inhibit its function by affecting RNA-dependent ATPase as well as translocase activities (step 2 in model I, Fig. 1 ; Linderoth & Calendar, 1991; Pani et al., 2006; Magyar et al., 1996 Magyar et al., , 1999 . If Rho translocation along the nascent RNA plays a major role in the termination process, it is likely that slowing the transcript elongation rate should overcome the defects caused by these inhibitors.
Rho mutants. We used four Rho mutants, G51V, Y80C, G324D and N340S, which are severely defective for termination (Chalissery et al., 2007) . The N-terminal mutants G51V and Y80C are defective in RNA loading and in the subsequent activation steps (step 1, described in Introduction; Chalissery et al., 2007) . G324D and N340S are in the secondary RNA binding channel and are defective in secondary RNA binding as well as in their RNA-dependent ATPase/translocase activities (step 2 described in Introduction; Chalissery et al., 2007) . Similarly to the Rho inhibitors, it is also expected that slowing the speed of RNAP will suppress the termination defects of the latter mutants. The defects caused by G51V and Y80C mutations (Chalissery et al., 2007) on the kinetically controlled Rho loading and activation steps should also be suppressed by the reduced transcription elongation rate.
NusG mutants. Transcription elongation factor NusG (Sen et al., 2008) interacts with Rho (Li et al., 1993; Pasman & von Hippel, 2000) , and is an essential component of Rhodependent termination in vivo (Sullivan & Gottesman, 1992; Cardinale et al., 2008) . In vitro, RNA release is significantly enhanced if NusG is added to the reaction (Burns et al., 1999; Chalissery et al., 2007) . This step may be more important in vivo because of the presence of other competing processes. If the Rho-NusG interaction during the in vivo termination process also enhances the speed of RNA release, mutations in NusG that are defective for Rho binding will slow RNA release and in a similar manner this defect in the termination process will also be suppressed by reducing the rate of transcript elongation. We used three NusG mutants, G146D, L158Q and V160N, which have been characterized for their defects in Rho binding (Chalissery et al., 2011) .
Genetic and physical means to modulate the rate of transcription elongation. Among the several rif R RNAP mutants reported, some have a low transcription elongation rate due to high K m for NTPs (Jin & Gross, 1991) . We used strains with two such mutants, rpoB8 (b subunit, Q513P) and rpoB3445 (b subunit, D507-511), present in the chromosome, to obtain a slow elongation rate and measure the suppression of the defects in the kinetically controlled steps of Rho-dependent termination. We also used another rif R RNAP mutant, rpoB2, which has a faster elongation rate, to demonstrate the opposite effect of rpoB8 and rpoB3445.
The transcription elongation rate is directly proportional to the growth rate of E. coli (Vogel & Jensen, 1994) . We therefore reduced the transcription rate by growing the cells in minimal medium, and the suppression activities of Rho-dependent termination defects were tested under these conditions. B8 RNAP is not a termination-or backtrackingprone enzyme and has a similar gene expression profile to WT It has been shown that B8 RNAP is more terminationprone at the hairpin-dependent terminator in vitro, which was attributed to slow NTP addition at the terminator sequences (McDowell et al., 1994) . Accordingly, it can be argued that the suppression of Rho defects, if any, by B8 RNAP could be due to the latter's termination-prone behaviour. Therefore, we first tested the behaviour of B8 RNAP towards Rho-dependent terminators in vitro (Fig.   2a) . The Rho-dependent termination behaviour of B8 RNAP was similar to that of the WT RNAP at the trpt9 terminator under different conditions. We also tested the backtracking potential of B8, as it has been observed to produce pauses due to slow incorporation of NTPs. We formed a stalled EC at a position where it tended to become arrested (Fig. 2b) . The WT RNAP became arrested due to backtracking, and could only be chased in the presence of GreB, whereas a significant fraction of B8 could be chased out without the help of GreB. This indicated that B8 RNAP is less prone to backtracking than its WT counterpart. Consistent with this, we also observed that the elongation kinetics of B8 RNAP were not affected in the presence of GreB (see Fig. S1 , available with the online version of this paper). We concluded that in the in vitro assays this enzyme is not intrinsically prone to termination or backtracking on Rho-dependent terminators.
It is also possible that the slow elongation rate of B8 RNAP affects the EC dissociation step, as at the termination site the termination efficiency is determined by the kinetic competition between the elongation and termination pathways (von Hippel & Pasman, 2002) . To test this, we measured the RNA release kinetics by Rho from stalled ECs made from either WT or B8 RNAP (Fig. 2b, upper panel) . Rho released RNA with comparable efficiency from ECs with either WT or B8 RNAPs (Fig. 2c, d ). This result rules out the possibility that the slow elongation rate of B8 RNAP has any effect on the EC dissociation step. From these two results we concluded that the suppression activity of the B8 enzyme, if any, is likely due only to its slow elongation rate.
We also compared the gene expression profiles of B8 and WT RNAPs in vivo by comparing microarrays of the MG1655rpoB8 and WT MG1655 strains (Fig. S2) . We plotted the ratios of the hybridization intensities obtained from the B8 strain to those obtained from the WT strain. The expression pattern of just a few genes, ,1 % of the total ORFs (a total of only 24 genes), was affected as a result of this mutation. We concluded that this mutation in RNAP does not cause a significant alteration in the gene expression pattern. This mutant behaves similarly to the WT strain, except that it has a slow transcription elongation rate, which is usually manifested as a slower growth rate. Therefore, the use of this strain to measure the suppression of the defects of Rho-dependent termination due to slow transcription elongation rate is justified.
In vivo assays
We employed growth assays and reporter-based transcription termination assays using the WT, rpoB8, rpoB3445 and rpoB2 strain backgrounds. Perturbations in the Rhodependent termination process cause growth defects and alter genome-wide gene expression profiles (Cardinale et al., 2008) . We therefore used growth assays together with reporter-based transcription assays to study in vivo Rho-dependent termination. We used the lacZ reporter
In vivo Rho-dependent termination fused directly downstream of a single Rho-dependent terminator, H-19B T R1 (Chalissery et al., 2007) , and also another construct in which the trpt9 region was inserted between lacZ and T R1 . The b-galactosidase activity from these constructs gives a quantitative measure of termination defects. In a few cases, we also used a microarray to analyse gene expression profiles under different conditions.
In all the in vivo assays, the transcription elongation rate was modulated by genetic means using strains harbouring RNAP mutations, rpoB8, rpoB3445 and rpoB2, in the chromosome (Jin & Gross, 1991; Jin et al., 1992) . The elongation rate was also changed by physical means such as growing the strains in minimal media (Vogel & Jensen, 1994) . MG1655 strains with different Rho and NusG mutations were grown in minimal media to study the suppression phenomenon, if any.
A slow elongation rate suppresses the actions of Rho inhibitors, Psu and BCM
Inhibition of Rho-dependent termination via expression of Psu and treatment with BCM caused severe growth defects in E. coli MG1655 strains (Fig. 3 , second panels; see also Pani et al., 2006; Cardinale et al., 2008) . This growth defect caused by WT Psu was significantly suppressed in the MG1655 strain (MG1655 B8) harbouring the rpoB8 and rpoB3445 mutations in the rpoB gene (Fig. 3a, third and fourth panels). This effect of Psu is specific, as a mutant Psu (E56K) that is unable to bind Rho did not show this defect. The MG1655 B8 and 3445 strains were also less sensitive to BCM treatment (Fig. 3b, third and fourth panels). Growth defects of the RNAP mutants were observed when the BCM concentration was ¢50 mg ml 21 , and this concentration was higher than that for WT and B2 RNAPs. Interestingly, the defects caused by Psu and BCM were more serious than those of the WT counterpart when the MG1655 B2 strain was used (Fig. 3, first panels) . In contrast to rpoB8, the rpoB2 mutation in RNAP increases the transcription elongation rate (Jin & Gross, 1991) .
The growth defects caused by these two Rho inhibitors are likely the result of unwanted gene expression occurring due to inefficient Rho-dependent termination events throughout the genome. To monitor the genome-wide expression profile, we performed microarray analysis under different conditions (Fig. 4a, b) . We measured the altered gene expression patterns of the strains after the BCM treatment by plotting the ratio of the hybridization intensities for each gene (Fig. 4a) . Similarly, Psu-mediated altered gene expression profiles were obtained by plotting the ratio of hybridization intensities obtained in the presence and absence of Psu induction (Fig. 4b) . These plots revealed genes that were either up-or downregulated due to the induction of Psu and treatment with BCM. We observed the following. (1) Psu has a more drastic effect on the gene expression profile than BCM, with about 25 % of the genes being affected. In general, these changes in gene expression profile indicate the presence of widespread Rho-dependent termination throughout the genome which inhibits unwanted gene expression. (2) In both cases, the presence of B8 RNAP reduced the gene expression very significantly (Fig.  4a, b, bottom panels) , which indicates restoration of Rhodependent termination events. As the presence of B8 RNAP also reduces the growth defect (Fig. 3) , it can be assumed that together with other genes the expression of unwanted growth-defective genes was also shut down.
It has been reported that the growth defects caused by compromised Rho-dependent termination are due to failed suppression of toxic genes in the rac prophage (Cardinale et al., 2008; Fig. 4c ). We therefore analysed the gene expression profile of the rac prophage region in detail (Fig.  4d, e) . Most of the rac prophage genes are upregulated in the presence of Psu induction and when treated with BCM. Therefore, Psu has effects on the gene expression profile similar to those of BCM. Consistent with the reduction in gene expression caused by B8 RNAP, expression of rac prophage genes was also significantly reduced by this RNAP (Fig. 4d, e) .
Next we measured the B8 RNAP-mediated suppression of the defect in Rho-dependent transcription termination caused by Psu. We measured expression of the lacZ gene fused to a Rho-dependent terminator (T R1 ), which manifests itself as red/pink colonies on MacConkey-lactose plates. The lacZ gene is expressed only if there is a termination defect. In the WT background (RS1022), expression of Psu exhibited the termination effect through this terminator and the colonies were red, whereas in the B8 background (RS1035), colonies were whitish, indicating suppression of the termination defect (Fig. 4f ).
All the above results indicated strongly that the reduction in the elongation rate by B8 and 3445 RNAP compensates for the reduced translocation rate of Rho caused by Psu (Pani et al., 2006) and BCM (Magyar et al., 1996 (Magyar et al., , 1999 . A further increase in the transcription elongation rate by B2 RNAP makes the strains more sensitive to these two agents. These results also suggest that translocase activity is an important step in Rho function.
Suppression of growth defects of Rho and NusG mutants by slow-moving RNAPs
MG1655Drho strains with WT, B8, B3445 and B2 RNAPs were transformed with the pCL1920 plasmids containing the Rho mutants. All the mutants caused growth defects in the WT strain (RS659; Fig. 5a, b) . The defect was most severe for the secondary RNA binding mutants (G324D and N340S; Fig. 5b ). Defects for primary RNA binding mutants (G51V and Y80C; Fig. 5a ) were milder, but their growth rates in the WT strain were also reduced significantly. This defect was less pronounced when the corresponding rpoB8 (RS705) and rpoB3445 (RS1185) strains were transformed with these mutants (Fig. 5a, b) . The milder growth defects of G51V and Y80C mutants became severe in the MG1655rpoB2 strains, where transcription elongation rates are faster than in the WT (Fig. 5c) . Therefore, modulation of elongation speed can either suppress the defects of these Rho mutants or cause a more severe phenotype.
We have recently described NusG-CTD mutants (G146D, L158Q and V160N) defective for interaction with Rho (Chalissery et al., 2011) . We tested the suppression of the termination defects of these NusG mutants by the two RNAP mutants. We transformed derivatives of MG1655DnusG strains (WT and rpoB8) with WT and different NusG mutants cloned in a modified pBAD vector (pHYD3011), which were plated at 42 u C to remove the NusG-shelter plasmids with a ts replicon. Like the Rho mutants, NusG mutants also exhibited growth defects in the MG1655 WT strain (RS863; Fig. 5d , top panels), whereas this defect was significantly suppressed in MG1655rpoB8 (RS1007) strains (Fig. 5d, bottom panels) . Therefore, a slow transcription elongation rate also makes the strains less dependent on the Rho-NusG interaction.
Suppression of transcription termination defects
Next we measured transcription termination defects caused by the Rho and NusG mutants and tested the suppression of these defects. We used two DNA templates in which the Rho-dependent terminator H-19B T R1 (Chalissery et al., 2007) was either fused directly to the lacZYA reporter cassette or the trpt9 region of the trp operon (Galloway & Platt, 1988) was inserted between the tR1 terminator and the reporter (see Fig. S3 for detailed sequence information). Due to this insertion, the distance traversed by the RNAP is significantly longer (Fig. S3) on the latter template than the former (Fig. 6a) . These two lacZYA reporters were present as a single-copy lysogen. If the elongation rate of RNAP is coupled to the translocation speed of the Rho, the probability of 'catching up' RNAP by Rho will be higher on the longer template, and therefore the efficiency of suppression of Rho mutants by the slower elongation rate will be higher on the T R1 -trpt9 template. On the other hand, if the speed of RNA release is affected by the NusG mutants, then the slow elongation rate will likely compensate for the NusG-mediated termination defects on the longer template because RNAP will spend more time on the former. The b-galactosidase activity from these two reporters will be proportional to the Rho-dependent termination defects under different conditions. The WT (GJ3192) and rpoB8 (RS446) strains with these two terminator cassettes were transformed by the pCL1920 plasmids containing the WT and different Rho and NusG mutants. Consistent with our previous observations IP: 54.70.40.11
On: Sun, 10 Mar 2019 00:20:08 Fig. 4 . B8 RNAP suppresses the altered genome-wide expression profile caused by the induction of Psu and the addition of BCM. To obtain alterations in the whole-genome expression profile, microarray analysis was performed on whole RNA from the WT MG1655 or MG1655 B8 strains either expressing Psu or treated with 25 mg BCM ml On: Sun, 10 Mar 2019 00:20:08 (Chalissery et al., 2007 (Chalissery et al., , 2011 , all these mutants, in the presence of WT RNAP (GJ3192), produced significantly high b-galactosidase activity due to a severe termination defect at the T R1 terminator fused directly to the reporter (Fig. 6b, c, left panels) . In the presence of B8 RNAP, this termination defect remained similar to the WT RNAP for this template (Fig. 6b, c, left panels) . Interestingly, this termination defect of Rho and NusG mutants was significantly suppressed by B8 RNAP on the longer template (Fig.  6b, c, right panels) , as manifested by the reduced bgalactosidase activity. The effect of B8 RNAP was modest on the G51V Rho mutant. However, when RNAP was allowed to travel through an even longer template, such as the galEP3 reporter (Fig. S4a) , B8 RNAP was able to suppress the defect of all the Rho and NusG mutants ( Fig. S4b, c ; indicated by whitish/pinkish colonies on MacConkey-galactose plates as opposed to the red colonies in the presence of WT RNAP). Therefore, a slow transcription elongation rate helps Rho to catch up the RNAP more efficiently on the longer DNA stretches of T R1 -trpt9 and galEP3 cassettes. These results correlate well with the suppression of growth defects of these mutants that result from a slow elongation rate (Fig. 5) . They are also consistent with our previous results, where we showed that the Rho mutants, defective for translocase activity, are able to release RNA efficiently from the stalled ECs (Chalissery et al., 2007, fig. 6f ). Stalled ECs offer sufficient time for the slow translocating Rho mutants to 'catch up' the RNAP.
Growth in minimal medium can suppress the transcription termination defects
Although we have shown that B8 RNAP is not significantly more prone to Rho-dependent termination in vitro, the slow elongation rate of B8 and similar RNAP mutants (such as rpoB3445) might make them more prone to pausing as well as termination in vivo. To address this we employed a physical means to reduce the transcription elongation rate. It has been shown that in less rich growth media, such as minimal media, the metabolism of E. coli slows down, leading to an at least twofold slower transcription elongation rate (Vogel & Jensen, 1994) . We therefore hypothesized that growth in minimal media may suppress the defects of Rho and NusG mutants.
The WT MG1655rac
+ strain was first transformed with plasmids containing different Rho and NusG mutants. The chromosomal copies of rho (strains with plasmids containing Rho mutants) or nusG (strains with plasmids containing NusG mutants) of these strains were deleted by inserting either rho : : kan R or nusG : : kan R cassettes by P1
transduction. The transductants were plated on either LB or on Minimal A plates (Fig. 7) . Consistent with the results shown in Fig. 4 , none of the transductants with either Rho or NusG mutants grew on LB plates. Interestingly, all these mutants grew on minimal medium plates with a colony size comparable with that of the WT. Therefore, slowing the metabolism by growing the strains in less rich medium suppresses the growth defect caused by Rho and NusG mutants. These results indicate that the defect in transcription termination properties of these mutants can also be restored by slowing the elongation rate via growth in less rich medium.
DISCUSSION
A major requirement for efficient Rho-dependent transcription termination in the conventional model (model I, Fig. 1 ) is that the translocase activity of Rho along the mRNA is required to bring it within the interacting distance of the elongating RNAP. Therefore, the motion of these two motors, Rho and RNAP, should be kinetically coupled, a concept which was proposed and experimentally supported based on observation of suppression of a Rho defect by a slow-moving elongating RNAP (Jin et al., 1992) . Here we have modulated the in vivo elongation rate by using three RNAP b-subunit mutants (B8, B2 and 3445) and by growing the strains in nutrient-poor medium. Slowing the transcription elongation rate suppressed the termination defects caused by various Rho and NusG mutants and those caused by the Rho inhibitors BCM and Psu, as described below. The following results may be noted:
(1) Suppression of the termination defects caused by the Rho-PBS mutants, G51V and Y80C (Figs 5 and 6), defective in kinetically controlled RNA binding and Rhoactivation steps (Chalissery et al., 2007) .
(2) Suppression of termination defects caused by Rho mutants (P279S, G324S and N340S; Figs 5 and 6) and Rho inhibitors (Psu and BCM; Figs 3 and 4), which affect the translocation speed of Rho along the RNA (Pani et al., 2006; Chalissery et al., 2007) .
(3) Suppression of termination defects caused by NusG-CTD mutants, G146D, L158Q and V160N (Figs 5 and 6), which affect the speed of RNA release by Rho from the EC (Chalissery et al., 2011) .
(4) A deleterious effect of a higher elongation rate on milder mutants such as Y80C and G51V (Fig. 5c ).
These results strongly suggest the in vivo existence of kinetically controlled steps in Rho-dependent termination In vivo Rho-dependent termination and also further reinforce the proposal of 'kinetic coupling' between RNAP and Rho during this event. As the defects in these mutants are in the kinetically controlled steps (see Introduction), it is likely that these steps are required for Rho function in vivo.
The above results also strongly support the conventional model (model I, Fig. 1 ) of Rho-dependent termination (Richardson, 2002; Banerjee et al., 2006) , wherein Rho loads onto the RNA and translocates along it to eventually interact with the EC. However, although this model is consistent with many of the properties of Rho, there has been no evidence for Rho loading onto and translocation along the mRNA in vivo. Suppression of the defects caused by various Rho and NusG mutants, and also that caused by the inhibitors BCM and Psu, by slowing the transcription elongation rate strongly suggests the existence of at least three kinetic steps in in vivo Rho-dependent termination: Rho activation by primary RNA binding, translocation along the RNA and RNA release. These observations, on the other hand, cannot be explained by the mechanism and nusG genes were expressed from pCL1920 plasmids and are indicated in the respective panels.
In vivo Rho-dependent termination described in model II (Fig. 1) , in which Rho travels with the EC and the termination process may not involve many of the kinetically controlled steps described above.
The presence of transcription elongation factor in the in vitro Rho-dependent termination assays causes early termination, which has been interpreted as a NusG-mediated increase in the speed of RNA release from the EC (Burns et al., 1999; Chalissery et al., 2007) . This effect of NusG is exerted due to its interaction with Rho via its CTD (Chalissery et al., 2011) . However, it has not previously been demonstrated that the requirement for NusG in in vivo Rho-dependent termination is also due to the increased speed of RNA release. Here we showed that B8 RNAP can overcome the in vivo transcription termination defects of NusG-CTD mutants, which not only were unable to interact with Rho but also failed to elicit the early termination phenomenon in vitro (Chalissery et al., 2011) . This observation can only be explained by the fact that a reduction in the transcription elongation rate makes Rho less dependent on NusG, which is possible if the in vivo function of NusG is also to increase the speed of RNA release from the EC. The efficiency of this final step is more important in vivo because the transcription elongation rate is much higher inside the cell than that observed under the limited NTP concentrations in vitro. In vivo, the NusG dependence of Rho may become mandatory on a subset of weaker Rho-dependent terminators, where the kinetically controlled steps such as Rho loading and translocation are compromised because of the presence of a suboptimal RNA sequence in the rut sites.
